Dexcom will stop producing G6 CGM sensors July 1, 2026, urging patients to switch to the smaller, more accurate G7 model.

Ensera Design’s Maartje Pel discusses how medtech is embracing women-specific innovation to address historical gaps.

Four major wearable tech companies are advancing blood pressure monitoring capabilities despite FDA warnings about medical ...

Staar Surgical reported a $80.4M full-year loss and 23.7% revenue decline, with analysts maintaining hold ratings as the ...

Vicarious Surgical is facing delisting from the New York Stock Exchange again. This is another setback the surgical robotics firm has faced in recent months. The NYSE sent the com ...

Mark McCarty has arguably the deepest reservoir of experience in med tech regulatory matters in all of the trade press. His ...

The approval comes on the heels of competition eating into Boston Scientific’s shares in the pulsed field ablation market.

Discover Vivani Medical's GLP-1 implant offering steady, reversible drug delivery to enhance adherence and reduce unnecessary ...

Corona, CA-based ETI will continue operating from its current facility while Cinova Medical completes the expansion of a new ...

Jack Heslin of Creatz3D explores how AI and 3D printing could create personalized invasive devices while highlighting ...

A federal judge ruled companies who paid Trump-era tariffs are owed refunds, potentially totaling $175B, as admin explores ...

Discover how Smith+Nephew's Landmark Knee System, featuring advanced kinematics, robotics, and more, could change the knee ...